India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
The facility features 2,176 high-performance GPUs across the US and Europe
At the center of the collapse is opposition from the Federal Trade Commission
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
Subscribe To Our Newsletter & Stay Updated
